
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
07/29/2025 | Q2 | $1.2B | -- | -- | $0.23 | -- |
04/30/2025 | Q1 | $1.2B | $1.1B | -$0.18 | -$0.23 | $0.05 |
02/20/2025 | Q4 | $1B | $1B | -$0.13 | -$0.55 | $0.42 |
10/29/2024 | Q3 | $1.1B | $1.1B | -$0.20 | $0.04 | -$0.24 |
07/30/2024 | Q2 | $1.3B | $1.2B | $0.29 | $0.15 | $0.14 |
04/30/2024 | Q1 | $1.2B | $1.2B | -$0.22 | $0.32 | -$0.54 |
02/21/2024 | Q4 | $1.1B | $1.1B | $0.76 | $0.18 | $0.58 |
10/30/2023 | Q3 | -- | -- | $1.00 | $0.34 | $0.66 |
06/30/2023 | Q2 | -- | -- | $1.06 | $1.36 | -$0.30 |
03/31/2023 | Q1 | -- | -- | $1.27 | $1.00 | $0.27 |
12/31/2022 | Q4 | -- | -- | -$0.65 | $0.72 | -$1.37 |
09/30/2022 | Q3 | -- | -- | $1.46 | $2.46 | -$1.00 |
06/30/2022 | Q2 | -- | -- | $5.10 | -- | -- |
03/31/2022 | Q1 | -- | -- | $4.17 | -- | -- |
12/31/2021 | Q4 | -- | -- | $2.71 | -- | -- |
09/30/2021 | Q3 | -- | -- | $1.27 | -- | -- |
06/30/2021 | Q2 | -- | -- | $2.91 | -- | -- |
03/31/2021 | Q1 | -- | -- | $0.66 | -- | -- |
12/31/2020 | Q4 | -- | -- | -$0.44 | -- | -- |
09/30/2020 | Q3 | -- | -- | -$1.05 | -- | -- |
06/30/2020 | Q2 | -- | -- | -$0.67 | -- | -- |
03/31/2020 | Q1 | -- | -- | $0.43 | -- | -- |
12/31/2019 | Q4 | -- | -- | $0.69 | -- | -- |
09/30/2019 | Q3 | -- | -- | $0.27 | -- | -- |
06/30/2019 | Q2 | -- | -- | $0.43 | -- | -- |
03/31/2019 | Q1 | -- | -- | $0.78 | -- | -- |
12/31/2018 | Q4 | -- | -- | $0.01 | -- | -- |
09/30/2018 | Q3 | -- | -- | $2.06 | -- | -- |
06/30/2018 | Q2 | -- | -- | $0.46 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.28 | -- | -- |
12/31/2017 | Q4 | -- | -- | -- | -- | -- |
09/30/2017 | Q3 | -- | -- | $0.05 | -- | -- |
06/30/2017 | Q2 | -- | -- | $0.02 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.40 | -- | -- |
12/31/2016 | Q4 | -- | -- | -$0.23 | -- | -- |
09/30/2016 | Q3 | -- | -- | $0.23 | -- | -- |
06/30/2016 | Q2 | -- | -- | $0.17 | -- | -- |
03/31/2016 | Q1 | -- | -- | $0.42 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.64 | -- | -- |
09/30/2015 | Q3 | -- | -- | $0.21 | -- | -- |
Ryerson Holding reported $1.1B worth of top line sales in its most recent quarter.
Ryerson Holding announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.23 per share.
Ryerson Holding reported $204.4M that represents $6.42 per share over the last quarter.
Ryerson Holding's earnings are forecast to decrease from -$0.26 per share to -$0.52 per share next year representing a decrease of -94.15%.
Ryerson Holding's next earnings date is July 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.